Welcome to the tag category page for APTIOM!
Brivaracetam is a medication used to treat partial-onset seizures in individuals of various ages, including infants. It is known to act by binding to the synaptic vesicle glycoprotein 2A (SV2A) in the brain, similar to another anticonvulsant medication called levetiracetam. However, Brivaracetam has a higher affinity for this receptor. It is believed to be more selective and has a 20-fold greater affinity for SV2A. Brivaracetam is available only with a doctor's prescription and is used as adjunctive therapy for the treatment of partial-onset seizures in adults, adolescents aged 16 and above, and infants aged one month and older. It is important to note that Brivaracetam cannot cure epilepsy but can help control seizures as long as it is continuously used. Common side effects of Brivaracetam include irritability, anxiety, and potentially severe psychotic symptoms such as hallucinations and delusions. It is classified as a Schedule V Controlled Substance due to the potential for euphoria at high doses.
